Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Items 501–600 of 1,000
Human leukocyte antigen and idiosyncratic adverse drug reactions
Usui, T., & Naisbitt, D. J. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.11.003 · Cited by 39
Carlessi, R., Köhn‐Gaone, J., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019 · Cited by 39
Pathophysiological Significance of Hepatic Apoptosis
Wang, K., & Lin, B. (2012) · ISRN Hepatology · doi:10.1155/2013/740149 · Cited by 46
Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation
Carrion, A. F., Czul, F., Arosemena, L. R., Selvaggi, G., Garcia-Buitrago, M. T., Tekin, A., Tzakis, A. G., Martin, P., & Ghanta, R. K. (2010) · International Journal of Endocrinology · doi:10.1155/2010/910636 · Cited by 39
MicroRNAs in injury and repair
Gerlach, C. V., & Vaidya, V. S. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1974-1 · Cited by 39
Rai, R., & Maheshwari, A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2206-2.00126-3 · Cited by 38
Pharmacogenetics of Idiosyncratic Adverse Drug Reactions
Pirmohamed, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_17 · Cited by 41
The Gastrointestinal Complications of Oncologic Therapy
Shafi, M. A., & Bresalier, R. S. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.004 · Cited by 40
Ofotokun, I., Lennox, J. L., Smithson, S. E., Lu, C., & Easley, K. A. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31811ec780 · Cited by 38
Clinical characteristics of 159 cases of acute toxic hepatitis
Kang, S. H., Kim, J. I., Jeong, K. H., Ko, K. H., Ko, P. G., Hwang, S. W., Kim, E. M., Kim, S. H., Lee, H. Y., & Lee, B. S. (2008) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2008.14.4.483 · Cited by 28
Wu, L., Liu, Z., Auerbach, S. S., Huang, R., Chen, M., McEuen, K., Xu, J., Fang, H., & Tong, W. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00719 · Cited by 40
Zhang, Y., Qi, X., Gong, L., Li, Y., Liu, L., Xue, X., Xiao, Y., Wu, X., & Ren, J. (2008) · Toxicology · doi:10.1016/j.tox.2008.04.005 · Cited by 38
Losartan-Induced Hepatotoxicity
Bosch, X. (1997) · JAMA · doi:10.1001/jama.1997.03550190036037 · Cited by 38
Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study
Rakhshan, A., Rahmati-Kamel, B., Saffaei, A., & Ardakani, M. T. (2023) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-130336 · Cited by 44
Howell, B. A., Siler, S. Q., & Watkins, P. B. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.02.007 · Cited by 37
Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
Wang, Y., Xiang, X., Huang, W., Sandford, A. J., Wu, S., Zhang, M., Wang, M.-G., Chen, G., & He, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-38452-z · Cited by 40
Mesalam, N. M., Al-Dhumri, S. A., Gabr, S. A., Ibrahim, M. A., Al‐Mokaddem, A. K., & Abdel‐Moneim, A. E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06544-1 · Cited by 37
Fulminant Hepatic Failure Secondary to Erlotinib
Liu, W., Makrauer, F. L., Qamar, A., Janne, P. A., & Odze, R. D. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.04.014 · Cited by 38
Severe acute liver injury associated with lumiracoxib
Pillans, P. I., Ghiculescu, R. A., Lampe, G., Wilson, R. B., Wong, R. C. W., & Macdonald, G. A. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07036.x · Cited by 37
Verstraelen, S., Peers, B., Maho, W., Hollanders, K., Rémy, S., Berckmans, P., Covaci, A., & Witters, H. E. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3288 · Cited by 38
Androgenic-Anabolic Steroids: From the Gym to Drug-Induced Liver Injury
Alves, A. S., Perdigão, S., Morais, S. A., Sousa, C. I. S., & Salvador, F. (2022) · Cureus · doi:10.7759/cureus.28798 · Cited by 38
Use of Arctium lappa Extract Against Acetaminophen-Induced Hepatotoxicity in Rats
El-kott, A. F., & Bin-Meferij, M. M. (2015) · Current Therapeutic Research · doi:10.1016/j.curtheres.2015.05.001 · Cited by 38
Risk of Acute Kidney Injury and Long-Term Outcome in Patients With Acetaminophen Intoxication
Chen, Y., Lin, C., Dai, M., Chang, P., Chen, J.-H., Huang, T., Wu, Y., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000002040 · Cited by 36
Human three-dimensional in vitro model of hepatic zonation to predict zonal hepatotoxicity
Ahn, J., Ahn, J.-H., Yoon, S., Nam, Y. S., Son, M.-Y., & Oh, J.-H. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0148-5 · Cited by 35
Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis
Calistri, L., Rastrelli, V., Nardi, C., Maraghelli, D., Vidali, S., Pietragalla, M., & Colagrande, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i46.7866 · Cited by 45
Zheng, B., Tian, Y., Liu, S., Yang, J., Wu, F., & Xiong, H. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02005 · Cited by 36
Clinical analysis of 275 cases of acute drug-induced liver disease
Li, L., Jiang, W., & Wang, J. (2007) · Frontiers of Medicine · doi:10.1007/s11684-007-0012-8 · Cited by 40
Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure
Kemp, D. C., & Brouwer, K. L. R. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.04.014 · Cited by 36
Wolverton, S. E., & Remlinger, K. A. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.02.001 · Cited by 36
Uridine Prevents Fenofibrate-Induced Fatty Liver
Le, T. T., Urasaki, Y., & Pizzorno, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087179 · Cited by 38
Trastuzumab-Induced Hepatotoxicity
Srinivasan, S., Parsa, V., Liu, C. Y., & Fontana, J. A. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l217 · Cited by 36
Gant, T. W., Baus, P. R., Clothier, B., Riley, J., Davies, R., Judah, D. J., Edwards, R., George, E., Greaves, P., & Smith, A. G. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.111-1241506 · Cited by 39
Cytochrome c: a non‐invasive biomarker of drug‐induced liver injury
Miller, T. J., Knapton, A., Adeyemo, O., Noory, L., Weaver, J., & Hanig, J. P. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1347 · Cited by 35
Overview on the mechanisms of drug-induced liver cell death
Grattagliano, I., Portincasa, P., Palmieri, V. O., & Palasciano, G. (2002) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32160-x · Cited by 36
Case Report: Chronic Liver Injury Related to Use of Bentazepam
Andrade, R. J., Lucena, M. I., Aguilar, J. M. V., Lazo, M., Camargo, R., Moreno, P., García-Escaño, M. D., Márquez, A., Alcántara, R., & Alcaín, G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005520523502 · Cited by 36
Schattner, A., Kozak, N., & Friedman, J. A. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200110000-00016 · Cited by 36
Li, X., Zhou, J., Chen, S., Guan, M., Wang, Y., Zhao, L., Ying, H., & Zhou, Y. (2014) · Journal of International Medical Research · doi:10.1177/0300060514527058 · Cited by 34
Paul, S., Islam, M. A., Tanvir, E. M., Ahmed, R., Das, S., Rumpa, N.-E.-N., Hossen, M. S., Parvez, M., Gan, S. H., & Khalil, M. I. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/9470954 · Cited by 35
RetractedMotawi, T. K., Mohamed, M. R., Shahin, N. N., Ali, M. A. M., & Azzam, M. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.05.002 · Cited by 37
Baba, A., & Yoshioka, T. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b608755h · Cited by 35
Lee, C., Yao, C., Huang, S., Ko, S., Tan, Y. C., Lee‐Chen, G., & Wang, Y. (2008) · Cancer · doi:10.1002/cncr.23619 · Cited by 35
Acetaminophen Dose Does Not Predict Outcome in Acetaminophen-Induced Acute Liver Failure
The Acute Liver Failure Study Group, Gregory, B., Larson, A. M., REISCH, J. S., & Lee, W. M. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181db8764 · Cited by 40
Self-citationTeo, D. C. H., Ng, P. S. L., Tan, S. H., Lim, A. T., Toh, D. S. L., Chan, S. Y., & Cheong, H. H. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1168-z · Cited by 34
Evaluation of oxidative status in acetaminophen treated rat hepatocytes in culture
Roušar, T., Kučera, O., Křiváková, P., Lotková, H., Kanďár, R., Mužáková, V., & Červinková, Z. (2009) · Physiological Research · doi:10.33549/physiolres.931437 · Cited by 36
Drug-induced liver injury and COVID-19: A review for clinical practice
Ortiz, G. X., Lenhart, G., Becker, M. W., Schwambach, K. H., Tovo, C. V., & Blatt, C. R. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i9.1143 · Cited by 34
Drug-induced liver injury: hepatotoxicity of quetiapine revisited
Shpaner, A., Li, W., Ankoma‐Sey, V., & Botero, R. C. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f8e3a0 · Cited by 34
Halladay, J. S., Wong, S., Khojasteh, S. C., & Grepper, S. (2012) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2012.07.004 · Cited by 39
Parmentier, C., Truisi, G. L., Mönks, K., Stanzel, S. F., Lukas, A., Kopp‐Schneider, A., Alexandre, E., Hewitt, P. G., Mueller, S. O., & Richert, L. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052415 · Cited by 37
Karim, A., Ahmed, S., Rossoff, L. J., Siddiqui, R., & Steinberg, H. N. (2001) · Clinical Infectious Diseases · doi:10.1086/338156 · Cited by 34
Hepatic injury due to drugs, herbal compounds, chemicals and toxins
Lewis, J. H., & Kleiner, D. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00013-1 · Cited by 36
Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics
Mussap, M., Loddo, C., Fanni, C., & Fanos, V. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1713750 · Cited by 39
Hepatoprotective effect of B athysa cuspidata in a murine model of severe toxic liver injury
Gonçalves, R. V., Novaes, R. D., Leite, J. P. V., Vilela, E. F., Cupertino, M. C., Nunes, L. G., & da Matta, S. L. P. (2012) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2012.00835.x · Cited by 35
High-throughputinvitroprofiling assays: lessons learnt from experiences at Novartis
Faller, B., Wang, J., Zimmerlin, A. G., Bell, L., Hamon, J., Whitebread, S., Azzaoui, K., Bojanic, D., & Urbán, L. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.823 · Cited by 33
Giri, S., Nieber, K., & Bader, A. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003792521 · Cited by 36
The role and advances of immunomodulator therapy for inflammatory bowel disease
Nielsen, O. H., Coskun, M., Steenholdt, C., & Rogler, G. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.945914 · Cited by 33
Liver overload in Brazilian triathletes after half-ironman competition is related muscle fatigue
Bürger-Mendonça, M., Bielavsky, M., & Barbosa, F. C. R. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31855-1 · Cited by 34
Levofloxacin-Induced Acute Fulminant Hepatic Failure in a Patient with Chronic Hepatitis B Infection
Çoban, Ş., Ceydilek, B., Ekız, F., Erden, E., & Soykan, İ. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g111 · Cited by 38
Quality Indicators for the Care of Osteoarthritis in Vulnerable Elders
MacLean, C. H., Pencharz, J. N., & Saag, K. G. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01346.x · Cited by 37
Zhang, C., Hong, H., Mendrick, D. L., Tang, Y., & Cheng, F. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.81 · Cited by 34
Amir, M., Khan, M. A., Ahmad, S., Akhtar, M., Mujeeb, M., Ahmad, A., Khan, S. A., & Al-Abbasi, F. A. (2015) · Natural Product Research · doi:10.1080/14786419.2015.1039001 · Cited by 32
Li, W., Yin, H., Bardelang, D., Xiao, J., Zheng, Y., & Wang, R. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.02.022 · Cited by 32
Teschke, R. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31764-8 · Cited by 35
Clindamycin-induced acute cholestatic hepatitis
Aygün, C. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i40.5408 · Cited by 32
Sanjay, S., Girish, C., Toi, P. C., & Bobby, Z. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0008 · Cited by 38
Effect of thiazolidinediones on bile acid transport in rat liver
Snow, K. L., & Moseley, R. H. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.11.001 · Cited by 32
Descloux, É., Argaud, L., Dumortier, J., Scoazec, J., Boillot, O., & Robert, D. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2846-3 · Cited by 32
Zhou, L., Pihlstrom, B. L., Hardwick, J. P., Park, S. S., Wrighton, S. A., & Holtzman, J. L. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90135-6 · Cited by 32
Cytochrome P450 isoenzymes—importance for the internist
Kerremans, A. L. M. (1996) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(96)00002-2 · Cited by 32
Near-infrared fluorescent Aza-BODIPY dyes: Rational structural design and biomedical imaging
Zhao, B., Liao, L., Zhu, Y., Hu, Z., & Wu, F. (2023) · Journal of Luminescence · doi:10.1016/j.jlumin.2023.120099 · Cited by 31
Martínez-Sena, T., Moro, E., Moreno‐Torres, M., Quintás‐Cardama, A., Hengstler, J. G., & Castell, J. V. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03474-8 · Cited by 33
Driessen, M., Kienhuis, A. S., Vitins, A. P., Pennings, J. L. A., Pronk, T. E., van den Brandhof, E., Roodbergen, M., van de Water, B., & van der Ven, L. T. M. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.06.844 · Cited by 31
Sex-specific gene expression in the BXD mouse liver
Gatti, D. M., Zhao, N., Chesler, E. J., Bradford, B. U., Shabalin, A. A., Yordanova, R., Lu, L., & Rusyn, I. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00110.2009 · Cited by 32
Eghbal, M. A., Taziki, S., & Sattari, M. R. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21542 · Cited by 31
Mechanisms of Hepatic Cholestatic Drug Injury
Kolarić, T. O., Ninčević, V., Smolić, R., Smolić, M., & Wu, G. Y. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00042 · Cited by 38
Elzagallaai, A. A., & Rieder, M. J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12505 · Cited by 35
miR‐122‐5p as a plasma biomarker of liver injury in fish exposed to microcystin‐ LR
Florczyk, M., Brzuzan, P., Krom, J., Woźny, M., & Łakomiak, A. (2015) · Journal of Fish Diseases · doi:10.1111/jfd.12406 · Cited by 31
Which psychotropic medications induce hepatotoxicity?
Sedky, K., Nazir, R., Joshi, A., Kaur, G., & Lippmann, S. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.10.007 · Cited by 32
Evaluation of High Dosages of Oral Meloxicam in American Kestrels (Falco sparverius)
Summa, N., Guzman, D. S.-M., Larrat, S., Troncy, É., Bird, D. M., Lair, S., & Fitzgérald, G. (2017) · Journal of Avian Medicine and Surgery · doi:10.1647/2015-150 · Cited by 31
Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole
Kouklakis, G., Mpoumponaris, A., Zezos, P., Moschos, J. M., Koulaouzidis, A., Νάκος, Α., Pehlivanidis, A. N., Iosiphidis, M., Molyvas, E., & Nikolaidis, N. L. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31956-8 · Cited by 32
Liu, Q., Cui, Z., Deng, C., Yang, C., & Tao, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1485190 · Cited by 36
Burban, A., Sharanek, A., Hüe, R., Gay, M., Routier, S., Guillouzo, A., & Guguen‐Guillouzo, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-01171-y · Cited by 30
El‐Aarag, B., Khairy, A., Khalifa, S. A. M., & El-Seedi, H. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205215 · Cited by 31
Fulminant hepatitis during self-medication with conjugated linoleic acid
Nortadas, R., & Barata, J. D. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31034-8 · Cited by 30
El‐Mowafy, A. M., Abdel-Dayem, M. A., Abdel‐Aziz, A., El-Azab, M. F., & Said, S. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.04.014 · Cited by 30
Comparative Hepatic Toxicity: Prechronic/Chronic Liver Toxicity in Rodents
Hardisty, J. F., & Brix, A. E. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522077 · Cited by 30
Chen, S., Ren, Z., Yu, D., Ning, B., & Guo, L. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22173 · Cited by 31
Description of Prototype Modes-of-Action Related to Repeated Dose Toxicity
Landesmann, B., Paraskevi, G. M., Sharon, M., & Maurice, W. (2012) · Joint Research Centre (European Commission) · doi:10.2788/71112 · Cited by 33
Nikravesh, H., Khodayar, M. J., Mahdavinia, M., Mansouri, E., Zeidooni, L., & Dehbashi, F. N. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.038 · Cited by 29
Seeff, L. B., & Fontana, R. J. (2011) · Wiley eBooks · doi:10.1002/9781444341294.ch24 · Cited by 29
Schiødt, F. V. (2008) · PubMed · Cited by 35
el-Din, S. H. S., El-Lakkany, N. M., Salem, M., Hammam, O. A., Saleh, S., & Botros, S. S. (2016) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/2231-4040.184594 · Cited by 29
Cancer Chemotherapy I: Hepatocellular Injury
Rodriguez-Frias, E. A., & Lee, W. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.007 · Cited by 29
Self-citationAtomoxetine-induced hepatitis in a child
Stojanovski, S. D., Casavant, M. J., Mousa, H. M., Baker, P., & Nahata, M. C. (2007) · Clinical Toxicology · doi:10.1080/15563650600795644 · Cited by 29
Toxicidad hepática causada por medicamentos: revisión estucturada
Paniagua, A. C., Posada, L. M. C., & Amariles, P. (2017) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.177 · Cited by 40
Paniagua, A. C., Amariles, P., Angulo, N., & Restrepo-Garay, M. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.11.008 · Cited by 29
Smith, P., Lavery, A., & Turkington, R. C. (2020) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2020.101691 · Cited by 32
Goyal, R. K., Srivastava, D., & Lessnau, K. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.5.608 · Cited by 30
Kim, K., Chung, M. W., Um, S. Y., Oh, J. S., Kim, S. H., Na, M.-A., Oh, H. Y., Cho, W., & Choi, K. H. (2008) · Metabolomics · doi:10.1007/s11306-008-0131-5 · Cited by 28
Appropriate analgesic prescribing for the general dentist.
Donaldson, M., & Goodchild, J. H. (2010) · PubMed · Cited by 33
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity
Patel, S. J., Luther, J., Bohr, S., Iracheta‐Vellve, A., Li, M., King, K. R., Chung, R. T., & Yarmush, M. L. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.13 · Cited by 28
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.